Source: Business Wire

Press Release: Glaukos : GlaukosProvidesCOVID-19PandemicUpdate

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retina diseases, today provided an update on the actions it is taking in response to the COVID-19 pandemic. In order to prioritize the health and safety of employees, healthcare professionals, patients and its communities, while continuing to support its customers, Glaukos has acted qu

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Thomas W Burns's photo - President & CEO of Glaukos Corp

President & CEO

Thomas W Burns

CEO Approval Rating

88/100

Glaukos is an ophthalmic medical device firm that creates micro invasive glaucoma surgery options for patients. Read more